Pain and Fascia Thickness After Steroid Injection in Plantar Fasciitis

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital

About this trial

The aim of this study is to evaluate the effects of local corticosteroid injection on pain, foot function index, and plantar fascia thickness in patients clinically diagnosed with plantar fasciitis, and to determine whether local corticosteroid injection is an appropriate treatment option for plantar fasciitis. For this purpose, the study plans to assess plantar fascia thickness using ultrasonography, evaluate pain using the Visual Analog Scale (VAS), and investigate the impact on daily living activities in patients who have been clinically diagnosed with plantar fasciitis and treated with local corticosteroid injections.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who were clinically diagnosed with plantar fasciitis and received corticosteroid injections

Disqualifiers

Pregnancy

Patients who have had more than one corticosteroid injection in the last 6 months

Patients with systemic inflammatory diseases

Patients who have previously undergone surgery in the heel area

Trial population

33 patients who volunteered to participate in the study and applied to the Physical Medicine and Rehabilitation Clinic of the SBÜ Istanbul Physical Therapy and Rehabilitation Education and Research Hospital and were diagnosed with plantar fasciitis clinically and received local corticosteroid injections will be included in the study.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

33 Participants
are grouped into 1 trial group
Group A: Plantar Fasciitis Patients with Corticosteroid Injection

Trial outcomes

Primary outcomes

1

Plantar fascia thickness

Plantar fascia thickness measured by ultrasound

Time frame
The thickness measurement will be evaluated immediately after the injection and 1 month after the injection.
2

Pain score

Pain score assessed with a visual analog scale between 0 and 100

Time frame
Pain will be assessed with a visual analog scale immediately after injection and 1 month later

Secondary outcomes

1

Foot functions

Foot functions will be assessed immediately after injection and 1 month after injection with the foot function index.

Time frame
Foot functions will be assessed immediately after injection and 1 month after injection with the foot function index.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: